Meclon

Clotrimazole and Metronidazole, the active ingredient in Meclon, is an antifungal and antiprotozoal combination presented as a vaginal formulation for vaginal use. It treats vulvovaginal candidiasis, bacterial vaginosis and mixed vaginal infections in adult women.

GNH USA supplies Meclon as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meclon combines an antifungal and antiprotozoal agent to treat common vaginal infections.

Vulvovaginal candidiasis: restores normal flora by eliminating Candida species and relieves itching and discharge. Bacterial vaginosis: eradicates anaerobic bacteria, reducing malodour and discharge. Mixed vaginal infections: simultaneously targets fungal and bacterial pathogens for comprehensive symptom control.

Adverse reactions may occur with vaginal use of Meclon.

Common Side Effects: - Vaginal irritation or burning sensation - Mild itching or redness - Increased vaginal discharge - Light‑headedness or headache

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling, or hives - Severe vaginal ulceration or necrosis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Liver enzyme elevation or hepatitis - Anaphylaxis or severe dizziness

Use Meclon only under medical supervision and observe the following precautions.

Assess for known hypersensitivity to clotrimazole, metronidazole or any excipients. Avoid use in the presence of active vaginal ulceration or severe inflammation. Do not exceed the prescribed duration of therapy. Monitor for secondary infections or persistent symptoms. Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Meclon may interact with other medicines; consider the following.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction with metronidazole. - Systemic azole antifungals: can increase clotrimazole levels and toxicity. - Warfarin: metronidazole may potentiate anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: metronidazole may reduce hormonal efficacy. - Anticonvulsants (e.g., phenytoin, carbamazepine): enzyme induction may lower metronidazole concentrations. - Topical steroids: may mask local irritation or infection signs.